CVS Oct 2024 60.000 call
| Previous Close | 2.5400 |
| Open | 2.3600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 60.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 2.2900 - 2.7300 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 838 |
ZacksNew Strong Sell Stocks for May 6th
DDD, ASO and CVS have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2024.
Barrons.comCVS Stock Discovers a Medicare Disadvantage
Shares in the drug chain and health insurer lost 19% after missing earnings and slashing guidance. The culprit: Costs for its Medicare Advantage plans.
Associated Press FinanceAetna agrees to settle lawsuit over fertility coverage for LGBTQ+ customers
Aetna has agreed to settle a lawsuit that accused the health insurer of discriminating against LGBTQ+ customers in need of fertility treatment. Under the deal announced Friday, the insurer will make coverage of artificial insemination standard for all customers nationally and work to ensure that patients have equal access to more expensive in-vitro fertilization procedures, according to the National Women’s Law Center, which represented plaintiffs in the case. Aetna, the health insurance arm of CVS Health Corp., covers nearly 19 million people with commercial coverage, including employer-sponsored health insurance.
